Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging.

Dynamic contrast-enhanced computed tomography (CT) was compared with 1.5-T magnetic resonance (MR) imaging with FLASH (fast low-angle shot), gadolinium-enhanced FLASH (Gd-FLASH), and T2-weighted fat-suppression (T2FS) sequences in 11 patients with hematologic malignancies, five with biopsy-confirmed hepatosplenic candidiasis treated with antifungal chemotherapy and six with a clinical history suggestive of acute hepatosplenic candidiasis. CT and MR images were separately interpreted in a prospective fashion. MR imaging showed lesions compatible with candidiasis in the liver in six patients, the spleen in five, and the kidneys in one. CT showed candidiasis-compatible lesions in the liver in three patients and the spleen in one; no renal lesions were shown. Differences between acute and treated candidal lesions were observed. Gd-FLASH images showed the most liver lesions (n = 106), followed by FLASH (n = 85), T2FS (n = 20), and CT (n = 18). MR imaging performed better than CT in distinguishing candidal hepatic lesions from recurrent lymphoblastic lymphoma in one patient and from hepatic infarcts in another. The results suggest that MR imaging may be superior to CT in detecting lesions of hepatosplenic candidiasis.     

原发性透明细胞型肝癌的CT和MRI诊断

目的 探讨原发性透明细胞型肝癌的影像表现,评价CT和MRI对该病的诊断价值.方法 回顾性分析19例经手术病理证实的原发性透明细胞型肝癌的CT和MRI表现.13例行CT平扫和动态增强扫描,8例行MR T1WI、T2WI和动态增强扫描.结果 CT平扫13例病灶均为低密度,其中9例病灶内部见不规则的更低密度影.增强后动脉期所有病灶均有强化表现,9例病灶不均匀强化,病灶中心有无强化的低密度区.门静脉期11例病灶呈相对低密度,2例呈等密度.3例可见环形强化的包膜.MR T1WI上5例病灶为低信号,3例为稍高信号.T2WI上5例病灶为混杂高信号,3例为等、低信号.MRI增强动脉期所有病灶均有显著强化.门静脉期和延迟期7例病灶为相对低信号,1例为等信号.2例病灶见环形强化的包膜.结论 CT和MRI可显示原发性透明细胞型肝癌的特征性表现,有助于提高该病的诊断准确性.     

肝脏炎性假瘤的CT及MRI征象

目的:探讨肝脏炎性假瘤的CT和MRI表现。方法:8例经手术病理证实的肝脏炎性假瘤。男5例,女3例,年龄35~65岁,平均53岁。8例均作CT平扫及增强扫描,其中3例行MR对比检查。结果:CT表现为1 个病灶6 例,2个病灶2例,共发现病灶10个。平扫9个病灶表现为低密度,1 个病灶表现为稍高密度。动态增强扫描2 个病灶动脉期显著强化,门脉期及延迟期中度强化;8个病灶动脉期无明显强化,门脉期及延迟期有不同方式的强化,主要表现为周边完整或不完整的环形或结节状强化,中心核心样强化及线状或不规则分隔样强化。MRI表现为2 例病灶T1WI呈低信号,T2WI呈稍高信号,1例病灶T1WI及T2WI均为等信号,动态增强扫描与CT相仿。结论:肝脏炎性假瘤的CT及MRI表现因其病理阶段不同而表现各异,诊断需结合临床,确诊尚依靠病理检查。     

Malignant lesions of the liver identified on T1- but not T2-weighted MR images at 1.5 T

The authors reviewed their 21/2-year experience with a magnetic resonance (MR) imaging protocol for a 1.5-T MR imager that included T2-weighted fat-suppressed spin-echo, T1-weighted breath-hold gradient-echo, and serial dynamic gadolinium-enhanced T1-weighted gradient-echo imaging to identify histologic types of malignant liver lesions more apparent on T1- than on T2-weighted images. MR images of 212 consecutive patients with malignant liver lesions were reviewed. T2-weighted, T1-weighted, and dynamic contrast-enhanced T1-weighted images were examined separately in a blinded fashion. Seven patients demonstrated liver lesions (lymphoma [two patients] and carcinoid, hepatocellular carcinoma, colon adenocarcinoma, transitional cell carcinoma, and melanoma [one patient each]) on T1-weighted images that were inconspicuous on T2-weighted images. In all cases, the lesions were most conspicuous on T1-weighted images obtained immediately after administration of contrast agent. Histologic confirmation was present for all seven patients. The consistent feature among these lesions was that they were hypovascular, due either to a fibrous stroma or to dense monoclonal cellularity. These results suggest that in some patients with hypovascular primary neoplasms, the lesions may be identified only on T1-weighted images, and that immediate postcontrast T1-weighted images are of particular value in demonstrating lesions.     

Hepatic parenchymal changes after ethanol injection in rabbits: Correlation of conventional and dynamic MR imaging with pathologic findings

The purpose of this study is to clarify the changes of peripheral normal liver parenchyma before and after ethanol injection, with respect to MR appearances and pathologic findings and, in so doing, to clinically evaluate the therapeutic effectiveness of percutaneous ethanol injection (PEI) therapy. The normal liver in 12 rabbits was injected with ethanol. We performed conventional and dynamic MR imaging and prepared the histopathologic specimens 1 week (group 1), 2 weeks (group 2), and 1 month (group 3) after ethanol injection. On conventional MR images, coagulative necrosis in the normal liver was demonstrated as an area of low signal intensity on T1-weighted images and high signal intensity on T2-weighted images in all groups. On dynamic MR images, contrast enhancement in the coagulative necrosis was not seen in groups 1 and 2; however, gradual and concentric enhancement was seen in the direction of the central necrotic portion from early-to-delayed phase image in group 3. Although signal intensity of the coagulative necrotic area in the normal liver after ethanol injection may mimic that of untreated or viable hepatocellular carcinoma (HCC) when clinically encountered on conventional MR images, coagulative necrosis of the normal liver parenchyma will be discriminated from viable HCC by using dynamic MR imaging.     

肝内周围型胆管细胞癌的CT表现

目的研究肝内周围型胆管细胞痛（IHPCC）的CT表现。方法17例经手术病理证实的IHPCC患者均经常规CT平扫和三期动态增强扫描。对所有患者的CT表现进行了回顾性分析。结果17例IHPCC患者中,肝脏左叶和右叶的病变分别见于13和4例;单发与多发病灶分别见于16和1例,圆形与分叶状病灶分别见于8和9例。病变直径2．1～11cm之间。在CT平扫像上,病变密度低于肝实质,CT值介于10—30HU。IHPCC伴胆管扩张和结石分别见于8和1例。病变区肝脏轮廓显示膨隆7例,外部轮廓萎陷6例。在动态增强CT像上,病灶边缘呈连续或不连续的薄环形强化,病灶内部呈线条状或网状强化。在延迟期CT像上,病灶内部不均匀强化较动脉期明显。结论IHPCC在CT平扫与动态增强CT像上具有特征性表现,尤其肝内发现边缘强化的低密度病灶伴胆管扩张,以及延迟期像上显著强化,高度提示本病。     

Imaging of osteoid osteoma with dynamic gadolinium-enhanced MR imaging

PURPOSE: To compare dynamic gadolinium-enhanced T1-weighted magnetic resonance (MR) imaging with nonenhanced T1-weighted and T2-weighted MR imaging and thin-section computed tomography (CT) for the demonstration of osteoid osteomas. MATERIALS AND METHODS: The images of 11 patients with pathologically proven osteoid osteomas who underwent nonenhanced MR imaging, dynamic gadolinium-enhanced MR imaging, and CT were retrospectively reviewed. Images obtained with all three techniques were scored for conspicuity of the osteoid osteoma relative to the surrounding bone. Time-enhancement curves were generated from signal intensity measurements of these lesions and the adjacent bone marrow. The mean imaging scores of the four techniques were compared, and the statistical significance was calculated by using a linear model with terms for method and patient. Pairwise comparisons were made by using the Tukey-Kramer adjustment for multiple comparisons. RESULTS: Compared with CT, dynamic gadolinium-enhanced MR imaging demonstrated the osteoid osteoma equally well in eight of 11 patients and with better conspicuity in three of 11 patients, although this difference was not statistically significant (P =.69). The dynamic gadolinium-enhanced MR images demonstrated the osteoid osteomas significantly better than the nonenhanced T1-weighted (P <.001) and T2-weighted (P <.001) MR images. On the dynamic gadolinium-enhanced MR images, nine (82%) of 11 patients had peak enhancement of the osteoid osteoma in the arterial phase with early partial washout, compared with slower, progressive enhancement of the adjacent marrow. This resulted in greatest lesion to marrow contrast material enhancement in the arterial phase. One osteoid osteoma had peak enhancement in the venous phase, and one showed progressive enhancement through all phases to 150 seconds. CONCLUSION: Osteoid osteomas can be imaged with greater conspicuity by using dynamic gadolinium-enhanced instead of nonenhanced MR imaging and with conspicuity equal to or better than that obtained with thin-section CT.     

Hepatic Cavernous Hemangioma in Cirrhotic Liver: Imaging Findings

Objective

To document the imaging findings of hepatic cavernous hemangioma detected in cirrhotic liver.

Materials and Methods

The imaging findings of 14 hepatic cavernous hemangiomas in ten patients with liver cirrhosis were retrospectively analyzed. A diagnosis of hepatic cavernous hemangioma was based on the findings of two or more of the following imaging studies: MR, including contrast-enhanced dynamic imaging (n = 10), dynamic CT (n = 4), hepatic arteriography (n = 9), and US (n = 10).

Results

The mean size of the 14 hepatic hemangiomas was 0.9 (range, 0.5-1.5) cm in the longest dimension. In 11 of these (79%), contrast-enhanced dynamic CT and MR imaging showed rapid contrast enhancement of the entire lesion during the early phase, and hepatic arteriography revealed globular enhancement and rapid filling-in. On contrast-enhanced MR images, three lesions (21%) showed partial enhancement until the 5-min delayed phases. US indicated that while three slowly enhancing lesions were homogeneously hyperechoic, 9 (82%) of 11 showing rapid enhancement were not delineated.

Conclusion

The majority of hepatic cavernous hemangiomas detected in cirrhotic liver are small in size, and in many, hepatic arteriography and/or contrast-enhanced dynamic CT and MR imaging demonstrates rapid enhancement. US, however, fails to distinguish a lesion of this kind from its cirrhotic background.     

Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis

To determine whether gadobenate dimeglumine (BOPTA) will adequately enhance cirrhotic liver parenchyma, and to document the enhancement patterns in cirrhosis, 14 cirrhotic and 20 non-cirrhotic patients were evaluated before and 60–120 minutes after gadolinium-BOPTA. Proof of liver cirrhosis was biopsy (6), surgical resection (3), and clinical follow-up (5). Enhancement effects were compared quantitatively by determining the liver signal-to-noise ratio (SNR) and signal enhancement in both populations. Qualitatively assessment of the liver enhancement was performed and classified as homogeneous or heterogeneous. Quantitative analysis: cirrhotic liver parenchyma presented a higher increase in SNR values, relative to noncirrhotic liver parenchyma, on postcontrast images. Likewise the signal enhancement of cirrhotic liver parenchyma was superior to non-cirrhotic liver on T1-weighted SE images (P = .02) and in-phase GRE images (P < .001). There was no statistical difference on out-of-phase GRE images. Qualitative analysis: on T1-weighted SE postcontrast images, cirrhotic liver parenchyma showed a homogeneous enhancement in 7 patients and heterogeneous in 7. Whereas on GRE images, cirrhotic parenchyma showed heterogeneous enhancement in 9 patients and homogeneous in 5 patients. The heterogeneous enhancement was due to the presence of hypointense nodules in 7 patients and hyperintense nodules in 2 patients. In conclusion, our study has shown that the hepatobiliary contrast agent Gd-BOPTA is effective in the cirrhotic liver, demonstrating an increased liver enhancement compared with non-cirrhotic patients.     

Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions

The aim of this study was to determine the value of delayed-phase imaging (DPI) of gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging for the evaluation of focal hepatic tumors compared with precontrast imaging and early dynamic phase imaging. The MR images were obtained in 48 patients with 98 focal hepatic tumors. Three-dimensional gradient-echo (GRE) imaging obtained before and 30, 60, and 1 h after administration of 0.1 mmol/kg of gadobenate dimeglumine. Each image set was analyzed qualitatively (lesion detection, conspicuity, delineation, and enhancement pattern on DPI) and quantitatively [signal-to-noise ratio (SNR), tumor–liver contrast-to-noise ratio (CNR)]. Improved lesion-to-liver contrast during the dynamic phase imaging was observed compared with precontrast images. The DPI showed a homogeneous enhancement of liver parenchyma and distinctive enhancement features of focal liver lesions: metastases (85%) showed a target shaped enhancement, and hepatocellular carcinomas (HCCs) showed an inhomogeneous (58%) or homogeneous enhancement (21%). The DPI showed better performance for the detection of metastases than other images by increasing lesion delineation (p<0.05). The absolute CNR of metastasis measured from periphery of the tumors on DPI was greater than precontrast and arterial phase imaging (p<0.05). The Gd-BOPTA during both dynamic and delayed phases provides valuable information for the characterization of focal liver lesions, and furthermore, Gd-BOPTA-enhanced DPI contributed to the improved detection of liver metastasis compared to precontrast and early dynamic imaging.     

K空间中心部分采集技术肝脏局灶性病变动态增强扫描

目的：探讨Ｋ空间中心部分采集技术肝脏局灶性病变ＭＲ动态增强扫描方法及临床意义。材料与方法：前瞻性研究１１７例肝脏局灶性病变,包括肝细胞性肝癌、肝细胞性肝癌介入治疗后、周围型肝内胆管细胞性肝癌、转移瘤、海绵状血管瘤及肝囊肿。轴位常规自旋回波Ｔ１加权成像及快速自旋回波Ｔ２加权成像后,采用平静呼吸状态下梯度回波Ｋ空间中心部分采集技术、７个连续层面８个时相动态增强扫描。结果：各例均动态增强扫描成功。动态扫描显示时间信号强度曲线在肝细胞性肝癌及肝细胞肝癌介入治疗后活癌组织部分呈速升速降型;胆管细胞癌呈渐升型;转移瘤呈环形强化,缓慢升高型;海绵状血管瘤呈速升平台型;肝囊肿无强化。结论：Ｋ空间中心部分采集技术肝脏局灶性病灶动态扫描,可以在平静呼吸下成像,显示肝脏局灶病变的血供状态特征,有助于术前病灶定性诊断。     

肝脏局灶性病变MR动态增强扫描及临床意义

目的探讨肝脏局灶性病变ＭＲ动态增强扫描方法及临床意义。方法作者前瞻性研究了１３６例肝脏局灶性病变，包括肝细胞性肝癌、周围型肝内胆管细胞性肝癌、转移瘤及海绵状血管瘤。采用平静呼吸状态下梯度回波Ｋ空间中心部分采集技术、７个连续层面８个时相动态增强扫描。结果各例均动态增强扫描成功。动态扫描显示时间信号强度曲线在肝细胞性肝癌呈速升速降型；胆管细胞癌呈渐升型；转移瘤呈环形强化，缓慢升高型；海绵状血管瘤呈速升平台型。结论平静呼吸下Ｋ空间中心部分采集肝脏动态扫描，可以显示肝脏局灶病变的血供状态，而且不同病变具有不同的强化特征。     

Malignant hepatic tumors: Changes on MRI after hepatic arterial chemoembolization – preliminary findings

This study describes the MR appearances of malignant hypervascular liver lesions pre- and post-hepatic-arterial chemoembolization, with correlation to serial imaging and clinical responses. Eight patients with malignant hypervascular liver lesions underwent pretreatment and posttreatment MR examination on a 1.5-T MR imager. MR sequences included T1-weighted spoiled gradient echo (SGE), T2-weighted fat-suppressed spin echo or turbo spin echo, and dynamic gadolinium-enhanced SGE images. All patients underwent pretreatment, initial posttreatment, and subsequent posttreatment MR studies. The histology of primary tumors included various types of hepatocellular carcinoma (HCC) (four patients: fibrolamellar HCC [one patient], HCC [two patients], mixed HCC/cholangiocarcinoma [one patient]) and liver metastases (four patients: untyped islet cell tumor [two patients], gastrinoma [one patient], carcinoid [one patient]). Response to chemoembolization was determined by three assessments: MR response, serial imaging response, and clinical response. The appearance of MR response to chemoembolization was determined based on the correlation with clinical and serial imaging response. The MR response of lesions that showed good clinical response included: increase in signal intensity on T1-weighted images (three patients), decrease in signal intensity on T2-weighted images (three patients), and negligible or minimal enhancement on immediate postgadolinium images (four patients) after chemoembolization. The most marked change in lesion appearance was observed in lesions < 1 cm, which had intense homogeneous enhancement on pretreatment MR studies and negligible enhancement on initial posttreatment MR examinations. MR response of lesions that showed moderate clinical response demonstrated a variety of lesion appearances from substantial change to minimal change. MR response of lesions that showed poor clinical response demonstrated no change in lesion appearances compared with the pretreatment MR study. Our results demonstrated change in appearance of liver lesions between pre- and post-hepatic-arterial chemoembolization MR studies. MR response correlated with response determined by serial imaging studies and clinical findings.     

Eosinophilic hepatic necrosis: magnetic resonance imaging and computed tomography comparison

OBJECTIVE: To compare the findings of magnetic resonance (MR) imaging with those of computed tomography (CT) of focal liver lesions related to peripheral eosinophilia. METHODS: For 12 patients with peripheral eosinophilia (>7%) examined with hepatic MR imaging and CT, 52 focal hepatic lesions larger than 0.5 cm, including 31 lesions simultaneously found on the 2 imaging modalities, were subjected to a comparative analysis of their imaging features. RESULTS: The total number of lesions distinguished from background liver was 39 (75%) on MR imaging and 44 (85%) on CT scans. On arterial phase images of 10 patients with comparable data, homogeneously hyperintense lesions were demonstrated more frequently (P = 0.006) on MR imaging (16 [50%] of 32 lesions) than on CT scans (4 [13%] of 32 lesions). Only 7 (22%) of the 32 hypoattenuating lesions on portal phase CT were depicted as hypointense lesions on portal phase MR images in 12 patients. On delayed phase images in 8 patients, the number of hyperintense lesions on MR images (9 [56%] of 16) was greater (P = 0.077) than that seen on the CT scans (4 [25%] of 16). CONCLUSIONS: For many focal hepatic lesions related to peripheral eosinophilia, dynamic MR imaging more easily demonstrates lesional enhancement on arterial and delayed phases than CT scans. Because of the higher degree of lesional enhancement of MR imaging compared with CT, the lesion-to-liver contrast may not be sufficient to distinguish the lesion from the background liver, resulting in decreased sensitivity of portal phase dynamic MR imaging.     

Effects of ami-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: Implications for tumor characterization

This study was devoted to tumor differentiation in liver MR T1-weighted imaging with superparamagnetic iron oxide (SPIO). Twenty-one patients with 40 liver lesions were studied at 1.5 T. Before and at least 45 minutes after SPIO administration, turbo-field-echo (TFE) T1-weighted, TFE T1 × T2*-weighted (MXT), and fat-suppressed turbo-spin-echo T2-weighted images were acquired. A quantitative analysis was performed blindly. On TFE T1-weighted images, the signal enhancement was ?33% ± 12 for the liver, ?24% ± 2 for adenomas and focal nodular hyperplasia, +60% ± 33 for the hemangiomas; metastases and cyst enhancement were not significant. After SPIO on TFE T1-weighted images, the hemangioma-to-liver signal ratio (149% ± 18) was definitely higher than the mean metastasis-to-liver signal ratio (90% ± 16). This T1-related differentiation ability lacked dramatically on TFE MXT images and, in one case, was reduced on post-SPIO TFE T1-weighted images by a long imaging delay after SPIO administration (2 hours).     

肝脏局灶性结节增生的MRI分析

目的：探讨肝脏局灶性结节增生（FNH）的MRI表现特点。方法：11例FNH共12个结节行MRI平扫,其中10例10个结节行动态增强。11例均经手术或穿刺活检证实。对病灶的MRI一般和特殊表现进行分析并与病理对照。结果：12个结节中T1WI呈稍低、等信号,T2WI呈稍高、等信号9个;T1WI呈等信号,T2WI呈稍高信号2个;T1WI呈低信号,T2WI呈高信号1个。12个结节中信号不均匀4个,9个结节见疤痕,2个结节见包膜,3个结节周围见胆管受压移位。增强扫描动脉期、门静脉期及延迟期均强化9个,2个结节动脉期强化,延迟期大部分实质低于正常肝组织,2个结节边缘见包膜样强化;6个病灶见疤痕强化,1个结节疤痕无强化,3个结节平扫与增强未见疤痕。结论：绝大多数FNH的MRI表现具有一定的特征性,少部分结节表现不典型,经认真观察与分析,能作出正确诊断。     

Rathke cleft cysts: CT, MR imaging, and pathologic features

The authors retrospectively reviewed the clinical, computed tomography (CT), and magnetic resonance (MR) imaging findings in seven patients with pathologically proved Rathke cleft cysts. All the cysts were located in the anterior sella turcica or the anterior suprasellar cistern. Five cysts had both intra- and suprasellar components, one was entirely intrasellar, and the other was predominantly suprasellar in location. The size of the cysts ranged from 8 to 20 mm. CT scans demonstrated low-density homogeneous lesions in four cases. On MR images of three of these four cases, the cysts had the same intensity as cerebrospinal fluid on T1- and T2-weighted images, while in the fourth case, the cyst was hyperintense on the T1-weighted images. In the remaining three cases, CT showed slight hyperdensity relative to brain parenchyma, suggestive of contrast enhancement. MR showed signal heterogeneity of these lesions with focal components of diminished signal intensity of T2-weighted images. These same foci appeared iso- to slightly hyperintense on T1-weighted images.     

Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics

PURPOSE: To describe the magnetic resonance imaging spectrum of appearances of liver metastases from pancreatic ductal adenocarcinoma. MATERIALS AND METHODS: We retrospectively evaluated the MRI exams performed between July 1996 and August 2001 in all patients who had liver metastases from pancreatic adenocarcinoma and histopathologic diagnosis from either the primary pancreatic tumor, liver metastases, or both. Sixteen patients were included in the study. All MR studies were performed at 1.5 T with a standard protocol including T1- and T2-weighted images and serial post-gadolinium spoiled gradient echo (SGE) images. Location, size, number, signal characteristics on T1- and T2-weighted images, and pattern of enhancement on serial gadolinium-enhanced SGE images were assessed. RESULTS: The diameter of metastases ranged from a few millimetres to 4 cm, and 12 patients (75%) had only lesions of 1.5 cm or less. Capsular-based liver metastases were found in 13 patients (81%) and three patients had only capsular-based lesions with a diameter under 1.5 cm. Hypervascular lesions were found in six patients (38%) and hypovascular lesions in 10 patients (62%). Perilesional enhancement was present in 10 patients (62%), with six patients (38%) having ring perilesional enhancement and eight patients (50%) having wedge-shaped perilesional enhancement. CONCLUSION: On MR imaging, hepatic metastases from pancreatic adenocarcinoma show a range of enhancement patterns. Hypervascular metastases are not rare. Capsular based distribution, small diameter, and perilesional enhancement are common features. This retrospective study describes the MR imaging spectrum of appearances of liver metastases from pancreatic adenocarcinoma in patients with histopathologic confirmation of the diagnosis.     

平扫和动态增强MRI诊断肝脏局灶性结节增生

目的 探讨肝脏避灶性结节增生（ＦＮＨ）的平扫和动态增强的ＭＲＩ表现及诊断价值。方法 回顾分析２２例２２个手术病理证实的肝脏ＦＮＨ的平扫及动态增强ＭＲＩ资料。结果 病灶平均大小为４．０５ｃｍ,４个病灶在Ｔ１ＷＩ及Ｔ２ＷＩ上呈典型等信号肿块,１８个为不典型信号肿块。８个在平扫ＭＲ上显示中央瘢痕。２１个病灶的实质部分在增强后动脉期呈明显均匀强化,在门脉期及延迟期呈等强化或强于肝实质。２个病灶在门脉期和延     

肝脏局灶性结节增生影像分析

目的 :分析肝脏局灶性结节增生 (FNH )的CT、MR及DSA表现 ,提高对本病的认识。方法 :6例经证实的FNH ,均行CT、MR及DSA检查。结果 :6例病灶CT平扫低密度者 4例 ,均匀或不均匀 ,2例为等密度。增强动脉期所有病灶均有明显强化 ,除中心瘢痕外病灶强化均匀一致 ,3例可见到中心或周边增粗、扭曲的动脉。门脉期和延迟期扫描 4例病灶为等密度 ,2例为略高密度。 3例伴有中心瘢痕 ,1例无强化 ,2例延迟强化。 2例行DSA检查 ,病灶内分布较均匀的新生血管团。MR检查 4例 ,T1 WI呈等信号或略低信号 ,T2 WI呈略高信号。 1例行Gd DTPA增强延迟期呈略高信号 ,中心瘢痕无明显强化。结论 :CT、MR及DSA检查可充分反映FNH的血供特点和病理特征 ,动态增强是诊断FNH最有效的影像学手段 ,在诊断和鉴别诊断中具有很大价值